International
The Morning Science

What science found today

‹
 

Research

This Fortnight in Medicine XXXVIII

Sensible Medicine · By Adam Cifu & MD ·

This Fortnight in Medicine XXXVIII

The Brief

  • The newsletter revisits discontinuing statins in older adults without cardiovascular disease, following up on an earlier fortnight discussion of a statin discontinuation trial.
  • It also covers pelacarsen and cardiovascular outcomes in patients with high lipoprotein(a).
  • The source is a newsletter roundup and gives no further trial results or figures.

Why it matters

Whether older adults without cardiovascular disease should stay on statins bears directly on prescribing decisions, and the source points to ongoing trial evidence on this question.

Who’s affected

  • clinicians who prescribe statins to older adults
  • older adults taking statins for primary prevention

Discontinuing Statins in Older Adults without Cardiovascular Disease Fortnight 33 , on which we discussed the last statin discontinuation trial. Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)

How do you feel about this?

0 Comments

    This Fortnight in Medicine XXXVIII – The Morning Science